Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Diagnostic Guidelines for Identifying and Monitoring Cognitive Impairment in Multiple Sclerosis: An IMSCOGS and ECTRIMS Delphi Consensus Statement

Author:Morrow, Sarah   Hancock, Laura   Nonino, Francesco   Desantis, Claudia   Schettino, Martino   Langdon, Dawn   Amato, Maria Pia   Schoonheim, Menno   

Session Name:P1: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 1  

Topic:Multiple Sclerosis  

Program Number:P1.011  

Author Institution:University of Calgary, Hotchkiss Brain Institute, calgary, AB, Canada  Cleveland Clinic, Cleveland, OH  Cochrane Review Group Multiple Sclerosis and Rare Diseases of the CNS, Italy  Royal Holloway, Egham, United Kingdom  University of Florence, Italy  Amsterdam University Medical Center, Amsterdam, Netherlands  

When the Roof is Missing: Unroofed Coronary Sinus Presenting with Embolic Strokes

Author:Rehman, Abdur   Desai, Harsh   Onken, Mitchell   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Stroke Secondary to Vasculopathy or Thrombosis  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.011  

Author Institution:Geisinger Medical Center, Danville, PA  

Spinal Cord Stroke in an Adult Following Chimeric Antigen Receptor-T Cell Therapy for B Cell Acute Lymphoblastic Leukemia

Author:Buyukkurt, Asli   Pardo-Villamizar, Carlos   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Rare Clinical Case Presentations  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.011  

Author Institution:Johns Hopkins University, Baltimore, MD  

First in Class ASO Targeting SNCA p.A53T Allele: Preclinical Efficacy

Author:Tyner, Christina   Smieszek, Sandra   Przychodzen, Bart   Apokotou, Olympia   Papastefanaki, Florentia   Polymeropoulos, Christos   Birznieks, Gunther   Taoufik, Era   Polymeropoulos, Mihael   

Session Name:P1: Movement Disorders: Parkinson's Disease Genetics, Biomarkers, and Basic Science 1  

Topic:Movement Disorders  

Program Number:P1.011  

Author Institution:Vanda Pharmaceuticals Inc., Washington, DC  Laboratory of Cellular and Molecular Neurobiology, Hellenic Pasteur Institute, Athens, Greece  

Moving From Grant Support to Non-profit Status: A Case Study in Financial Independence for a Patient-focused Program

Author:Ingersoll, Sarah   Mendenhall, Kris   Hayashida, Kenneth   Castro, Louis   

Session Name:P1: Practice, Policy, and Ethics 1  

Topic:Practice, Policy, and Ethics  

Program Number:P1.011  

Author Institution:University of Southern California, Pasadena, CA  Parkinson's Foundation Research Advocate, CA  retired, CA  Castropt.com, CA